RAMM Pharma (XCNQ:RAMM) Common Stock: C$60.99 Mil (As of Jan. 2026)


What is RAMM Pharma Common Stock?

RAMM Pharma XCNQ:RAMM Common Stock is C$60.99 Mil as of Jan. 2026. The stock has 4 warning signs investors should review.

RAMM Pharma's quarterly common stock stayed the same from Jul. 2025 (C$60.99 Mil) to Oct. 2025 (C$60.99 Mil) and stayed the same from Oct. 2025 (C$60.99 Mil) to Jan. 2026 (C$60.99 Mil).

RAMM Pharma's annual common stock stayed the same from Oct. 2023 (C$60.99 Mil) to Oct. 2024 (C$60.99 Mil) and stayed the same from Oct. 2024 (C$60.99 Mil) to Oct. 2025 (C$60.99 Mil).

RAMM Pharma Common Stock Historical Data

* Premium members only.

The historical data trend for RAMM Pharma's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RAMM Pharma Common Stock Chart

RAMM Pharma Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Common Stock
Get a 7-Day Free Trial 63.06 62.53 60.99 60.99 60.99

RAMM Pharma Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.99 60.99 60.99 60.99 60.99

RAMM Pharma Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of C$60.99 Mil mean?
RAMM Pharma (XCNQ:RAMM) has a Common Stock of C$60.99 Mil as of Jan. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on RAMM Pharma and its competitors.
Is RAMM Pharma's Common Stock too high?
RAMM Pharma's current Common Stock is C$60.99 Mil.
How does RAMM Pharma's Common Stock compare to ZTS and UTHR?
RAMM Pharma's Common Stock of C$60.99 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on RAMM Pharma and its competitors. RAMM Pharma's current Common Stock is C$60.99 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RAMM Pharma stock overvalued right now?
Based on GuruFocus' analysis, RAMM Pharma (XCNQ:RAMM) is currently considered Fairly Valued. The stock's GF Value™ is C$0.01, compared to a current price of C$0.01 — trading right at its estimated fair value. The current Common Stock is C$60.99 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For RAMM Pharma (XCNQ:RAMM), the current Common Stock is C$60.99 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RAMM Pharma Business Description

Address 82 Richmond Street E, Toronto, ON, CAN, M5C 1P1
RAMM Pharma Corp is engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. The group generates revenue from the sale of medical devices and consumables, the sale of pharmaceutical products, and sale of cosmetics. Geographically, it derives a majority of its revenue from Uruguay.